Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Professors Sallie Lamb and Alan Silman on being appointed to serve on assessment sub-panels for the next Research Excellence Framework (REF) 2021.

The REF assesses the quality and impact of research in UK higher education institutions and determines their core funding.

The process is structured in two phases, the criteria phase taking place this year and the assessment phase, which will commence in late 2020 and continue throughout 2021. The latter will involve the full assessment of submissions made by institutions.

Sallie Lamb, Kadoorie Professor of Trauma Rehabilitation and Director of the Centre for Statistics in Medicine at NDORMS is an interdisciplinary advisor for sub-panel 3 (Allied Health Professions, Dentistry, Nursing and Pharmacy). This is a new role introduced for REF 2021.

Speaking of the appointment, Professor Lamb said: "I am looking forward to contributing to the development of new and important perspectives in the REF. Team science and excellence in inter-disciplinary research will be at the core of innovation and University research cultures of the future."

Professor of Musculoskeletal Health at NDORMS, Alan Silman will serve on sub-panel 2 (Public Health, Health Services and Primary Care). Professor Silman has supported the previous three exercises, both as chair and vice-chair of sub-panels and brings a lot of experience to the assessment team.

"My previous experience has provided substantial insights into how research is evaluated, given the number of different dimensions of assessment. Weighing up the contribution of the novelty of the question, the complexity of the methods and the value of the actual results is never easy. Chairing a previous epidemiology panel was a particular challenge given our desire that the assessment exercise should follow the same ideals of freedom of bias and reproducibility that should underscore any robust epidemiological study!", said Professor Silman.

Chairs and members of the main panels and sub-panels were appointed by the four UK higher education funding bodies following an open nominations process by subject associations and other organisations with an interest in research. Over 4,000 nominations were made for roles across the four main panels and the 34 sub-panels.

The panel members include leading researchers and individuals with expertise in the wider use and benefits of research, as well as members with an international perspective on the main panels.

You can see the full panel and sub-panel membership here.

About the REF

REF2021

See the full panel and sub-panel membership here

Similar stories

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Womens Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.

NDORMS academics named NIHR Senior Investigators

Main

Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.